How Long Should You Be in Afib Before Going to the Hospital?

Any episode of atrial fibrillation that causes chest pain, fainting, severe shortness of breath, or signs of stroke warrants an immediate call to emergency services, regardless of how long the rhythm has been going on. Outside those alarm symptoms, the medically meaningful threshold is 48 hours: once AFib has lasted that long, the risk of a blood clot forming in the heart rises enough that restoring normal rhythm without weeks of blood-thinner therapy becomes unsafe. That 48-hour window shapes nearly every clinical decision about AFib in the emergency department, and understanding it can help you decide when waiting at home is reasonable and when it is not.

Why 48 Hours Is the Critical Cutoff

When the upper chambers of the heart quiver instead of contracting normally, blood can pool and clot. The longer fibrillation continues, the more opportunity clots have to form. Research using imaging of the heart’s left atrial appendage has shown that thrombus can begin forming during the acute phase of AFib, not just after days or weeks of it, though the risk climbs with time.¹ Canadian cardiovascular guidelines state that if a physician is confident AFib has been present for clearly less than 48 hours and the patient is not at particularly high stroke risk, cardioversion can proceed without prolonged anticoagulation. When the duration is over 48 hours or uncertain, the patient should receive therapeutic blood thinners for at least three weeks before and four weeks after any attempt to restore normal rhythm.²

This matters to you because it changes what doctors can do when you arrive. Show up within the first day and the ER team has more options, including electrical or chemical cardioversion to snap your heart back to normal rhythm right there. Show up two or three days into an episode with no certainty about when it started, and the safest path is usually rate control (slowing the heart rate with medication) plus weeks of anticoagulation before anyone attempts cardioversion. In practical terms, getting to the hospital sooner gives the medical team a wider toolkit.

Symptoms That Mean Go Now

Duration is only one piece of the puzzle. Certain symptoms during AFib suggest the heart is struggling to keep up with the body’s demands, and those symptoms override any clock. You should seek emergency care immediately if you experience:

Chest pain or pressure: could indicate reduced blood flow to the heart muscle.
Fainting or near-fainting: suggests dangerously low blood pressure or a very fast or very slow heart rate.
Severe breathlessness at rest: may signal fluid backing up into the lungs.
Stroke symptoms: sudden weakness on one side, slurred speech, vision loss, or confusion.
Heart rate above roughly 150 beats per minute that won’t come down: sustained fast rates increase the risk of heart failure.

Data from a digital monitoring program found that when patients with AFib were escalated to urgent care, the most common reasons for hospital admission were AFib with a fast ventricular rate and decompensated heart failure.³ One patient was also admitted after developing a rhythm that alternated between dangerously fast and dangerously slow rates, requiring a permanent pacemaker. These are the scenarios where waiting is genuinely dangerous.

Many Episodes End on Their Own

If your symptoms are mild, your heart rate is not extremely fast, and you have no chest pain, breathlessness, or neurological symptoms, there is a reasonable chance the episode will stop by itself. A study of patients presenting with new-onset symptomatic AFib found that about a third converted spontaneously within the first eight hours, and roughly three-quarters did so within 24 hours of arriving at the emergency department.⁴ A larger earlier study found spontaneous conversion in about two-thirds of patients, with presenting within 24 hours of symptom onset being the strongest predictor of whether the heart would reset itself.⁵

Rates vary across studies depending on how long patients were observed. A review of multiple trials showed spontaneous conversion rates climbing steadily with observation time: around 60% at 24 hours, roughly 77% by 48 hours, and about 70% by 72 hours in one older cohort.⁶ The takeaway is that for recent-onset AFib, a substantial majority of episodes resolve without electrical shock or rhythm drugs, given enough time. But “given enough time” does not mean sitting at home hoping for the best. These patients were being monitored, their heart rates were controlled with medication, and clinicians were ready to intervene if things worsened.

The Wait-and-See Approach in the ER

A landmark Dutch trial randomized patients with recent-onset AFib to either immediate cardioversion or a “wait-and-see” strategy with rate control alone. At four weeks, about 91% of the wait-and-see group and 94% of the early-cardioversion group were in normal rhythm, a difference small enough that the delayed approach was considered noninferior. In the delayed group, roughly 69% converted spontaneously within 48 hours on their own, and another 28% underwent cardioversion later.⁷ Cardiovascular complications in the following four weeks were similar between groups.

A smaller pilot study tested a structured version of this approach: patients were rate-controlled in the ER, sent home, and asked to return the next day. About 63% had already converted by the time they came back, and the rest were cardioverted successfully at that second visit. No one needed hospital admission, and patient satisfaction was high.⁸ These findings support the idea that for hemodynamically stable patients with recent-onset AFib, early cardioversion is not always necessary. But the key detail is that these were patients being medically managed, not people riding out an episode alone at home. Rate control and monitoring matter even when the strategy is patience.

Why Early Rhythm Control Still Matters Long Term

While the wait-and-see approach is safe in the short term for stable patients, there is growing evidence that getting rhythm under control sooner rather than later has long-term benefits. A large registry study found that patients with first-diagnosed AFib who did not receive rhythm control during their initial ER visit had a higher rate of death and heart attack during follow-up compared to those who did.⁹ That does not mean every patient needs immediate cardioversion, but it does suggest that establishing a rhythm-control plan early, even if cardioversion itself is deferred, is better than simply rate-controlling indefinitely and hoping the problem goes away.

When AFib persists at fast heart rates for weeks or months, the heart muscle itself can weaken. This is called tachycardia-induced cardiomyopathy, and it typically develops when ventricular rates stay above roughly 120 beats per minute for sustained periods.¹⁰ The good news is that this form of heart failure is reversible: once the rate is controlled or the rhythm is restored, heart function usually recovers within about six months. The bad news is that recurrent tachycardia after recovery causes a rapid decline in heart function that can lead to serious heart failure.¹¹ This is why letting AFib persist unchecked at high rates, even if you feel okay, is not harmless.

The Pill-in-the-Pocket Option

Some people with recurrent AFib episodes are given a prescription strategy called “pill in the pocket,” where they take a single dose of an antiarrhythmic drug at home when an episode starts, rather than going to the ER each time. The original study of this approach found that patients took the medication within about half an hour of symptom onset and the drug terminated the episode in 94% of cases, with symptoms resolving in under two hours on average.¹² The approach works best when used early, ideally within the first three days of an episode, after which its effectiveness drops off, likely because the heart begins to remodel electrically in ways that sustain the arrhythmia.¹³

This is not a do-it-yourself strategy. The first dose is supposed to be taken under medical supervision because about 3% of patients in one study had significant adverse events, including dangerous drops in heart rate and blood pressure, fainting, and a fast flutter rhythm that required emergency treatment.¹⁴ If the first supervised dose goes well, patients can use it at home for future episodes, which cuts down on ER visits substantially. But if your doctor hasn’t set this up for you in advance, it is not an option you can improvise during an episode.

Silent AFib and Not Knowing When It Started

One of the trickiest aspects of the “how long” question is that many people cannot reliably tell when AFib started, or even whether they are currently in it. Research comparing patients’ self-reported rhythm to actual monitor recordings found that perception of their own rhythm is often inaccurate.¹⁵ Some people feel every skipped beat; others are in AFib for hours or days without knowing.

Silent AFib is not benign. A study of people with type 2 diabetes found that brief silent episodes of AFib were an independent predictor of stroke, with affected individuals experiencing stroke events at roughly three times the rate of those without silent AFib during a follow-up period averaging about three years.¹⁶ Interestingly, though, a more recent trial looking specifically at subclinical AFib found that the duration of the longest episode, whether under one hour or over six hours, did not clearly predict stroke risk once anticoagulation decisions were being considered.¹⁷ The practical message is that if you cannot pinpoint when your AFib began, the ER team will treat the duration as uncertain, which means anticoagulation before any cardioversion attempt, the more cautious path.

Smartwatches and Timing Your Episode

Consumer wearables have changed the landscape here. A systematic review of Apple Watch ECG recordings found a pooled sensitivity of about 95% and a specificity of about 95% for detecting AFib.¹⁸ That is accurate enough to be genuinely useful for timestamping the start of an episode. If your watch alerts you to an irregular rhythm and you take a reading that confirms AFib, that timestamp can help an ER doctor decide whether you are still inside the 48-hour cardioversion window. It does not replace a clinical ECG, but it can provide supporting evidence of onset time that your memory alone cannot.

If you have known paroxysmal AFib and wear a device, consider saving or screenshotting alerts and ECG tracings when they occur. Bringing that record to the ER can meaningfully affect your care pathway. Without it, if you woke up already in AFib with no idea when it started overnight, clinicians may have to assume the worst-case duration.

Pregnancy and AFib

AFib during pregnancy is uncommon but carries elevated risk because of the hemodynamic demands pregnancy places on the heart. Guidelines indicate that management should follow the same principles as in non-pregnant patients but with faster intervention, even in women with otherwise normal heart function, and with careful medication selection to avoid fetal harm.¹⁹ Electrical cardioversion is considered safe during pregnancy when the mother is hemodynamically unstable.²⁰ The threshold for going to the hospital is therefore lower during pregnancy: do not wait to see if the episode resolves on its own.

When Anxiety Complicates the Picture

AFib and anxiety have a bidirectional relationship that makes the “should I go to the hospital?” question harder than it sounds. A systematic review found that anxiety is linked to increased ER visits and hospitalizations among AFib patients, suggesting it amplifies symptom awareness and distress.²¹ Separately, about 37% of AFib patients report symptom preoccupation, which was strongly associated with worse quality of life and higher healthcare use.²²

This does not mean anxious patients are overreacting or that their symptoms are imaginary. AFib genuinely feels alarming, and anxiety can make a fast heart rate feel faster. The practical approach is to have a written action plan developed with your cardiologist that spells out: at what heart rate to take a rate-control medication, how long to wait, and at what point to call for help. Having clear criteria in advance reduces the guesswork during an episode and can prevent both unnecessary ER visits and dangerous delays.

What Happens When You Arrive at the ER

A population-level study of emergency medical services found that among people with a first AFib episode transported by ambulance, the median age was 76, about 72% had a heart rate of 100 or above, and over half were ultimately discharged from the emergency department without admission.²³ That means a trip to the ER for AFib does not automatically mean a multi-day hospitalization. For many patients, the visit involves confirming the rhythm on an ECG, checking bloodwork, controlling the heart rate with medication, assessing stroke risk, starting anticoagulation if needed, and going home within hours.

When cardioversion is attempted, it is highly effective. A decade-long review of electrical cardioversion for acute AFib in the ER found success in about 96% of cases, with no strokes, major bleeding, or life-threatening arrhythmias reported during the study. About 8% of patients returned to the ER within 30 days, mostly due to AFib recurrence.²⁴ Anticoagulation around cardioversion has also been shown to be safe: in a large trial comparing two blood thinners in patients undergoing cardioversion, no strokes or systemic clots occurred in the 30-day follow-up period in either group.²⁵

The Cost of Caution Versus the Cost of Delay

There is an understandable tension between not wanting to “waste” an ER visit and not wanting to wait too long. The financial reality is that AFib-related ER visits in the United States are substantial, with adjusted annual hospital charges for admitted AFib patients climbing from about $7.4 billion in 2007 to over $10 billion by 2014, even as the proportion of patients who needed admission gradually fell from around 70% to 62%.²⁶ That declining admission rate reflects better outpatient management and ER protocols, meaning more patients are being treated and sent home efficiently.

If cost or inconvenience is making you hesitate, consider what is at stake. The blood-clot risk of staying home past the 48-hour window, the potential for sustained fast rates to weaken your heart over time, and the narrowing of your treatment options all argue for erring on the side of being seen. A short, uneventful ER visit where your rate is controlled and you go home the same day is a far better outcome than a stroke caused by a clot that formed while you were debating whether the trip was worth it. If you have a pre-arranged plan with your cardiologist for managing mild episodes at home, follow that plan. If you do not, and your episode is new or unfamiliar, the hospital is the right call.

Blood Thinners and Residual Clot Risk

Even when anticoagulation is started promptly, clot resolution is not guaranteed in three weeks. A study using imaging before and after three weeks of a direct oral anticoagulant found that among patients who had a clot visible on baseline imaging, 70% still had a clot present at the follow-up scan. Some showed a reduction in clot size, but others had no visible change at all.²⁷ This is a reminder that the three-week anticoagulation window before cardioversion is a minimum, not a guarantee of clot clearance. For patients whose imaging shows persistent clot, cardioversion is typically delayed further. It is another reason why getting into the medical system early, while the episode is still fresh and options are open, is better than waiting until you have crossed thresholds that make management slower and more complicated.